Perjeta

4 Topics Found
Perjeta Pertuzumab

Pertuzumab, sold under the brand name Perjeta, is a monoclonal antibody used in combination with trastuzumab and docetaxel for the treatment of metastatic HER2-positive breast cancer; it also used in the same combination as a neoadjuvant in early HER2-positive breast cancer.[2] Side effects in more than half the people taking it include diarrhea, hair loss, and loss of neutrophils; more than 10% experience loss of red blood cells, hypersensitivity or allergic reaction, infusio...

Has anyone experienced cold like symptoms for an extended length of time after their last Perjeta infusion? I have had a stuffy nose since last May. My last infusion was in October. People have suggested it might be allergies but these aren't the normal symptoms of the allergies I used to have. The syptoms don't come and go. It has been every day. My Oncologist doesn't believe Perjeta has anything to do with my condition. Any help would be appreciated. Thank you ## Hello, Janine! How are you? It would be very unusual for side effects from the Perjeta to linger that long after your last infusion. Our bodies do change with time, so it could very well be a new allergy or an existing one that has gotten worse. Have you tried consulting an allergist? ## Thank you so much for your...

2 REPLIES Filed under Perjeta
Pertuzumab Drug Index

Pertuzumab, sold under the brand name Perjeta, is a monoclonal antibody used in combination with trastuzumab and docetaxel for the treatment of metastatic HER2-positive breast cancer; it also used in the same combination as a neoadjuvant in early HER2-positive breast cancer.[2] Side effects in more than half the people taking it include diarrhea, hair loss, and loss of neutrophils; more than 10% experience loss of red blood cells, hypersensitivity or allergic reaction, infusio...

NDC 50242-145 NDC Database

Perjeta 30 mg/ml Intravenous Injection, Solution, Concentrate by Genentech, Inc. ## Package Codes: 50242-145-01 ## Active Ingredients: Pertuzumab

Can't find what you're looking for?